Literature DB >> 28084806

Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review.

Peter Penson1, Maria-Corina Serban2, Sorin Ursoniu3, Maciej Banach4,5,6.   

Abstract

Coffee consumption alters plasma lipid and cholesterol concentrations, however, its effects on lipoprotein(a) (Lp(a)) have received little study. The aim of this PRISMA compliant systematic review was to examine the role of coffee on serum Lp(a). This study was prospectively registered (PROSPERO 2015:CRD42015032335). PubMed, Scopus, Web of Science and Cochrane Central were searched from inception until 9th January 2016 to detect trials and epidemiological studies investigating the impact of coffee on serum Lp(a) concentrations in humans. We identified six relevant publications describing nine experimental trials of various designs. There were a total of 640 participants across all studies and experimental groups. In short-term controlled studies, consumption of coffee, or coffee diterpenes was associated with either a reduction in serum Lp(a) of ≤11 mg/dL (6 trials, 275 participants), or no effect (2 trials, 56 participants). Conversely, one cross-sectional study with 309 participants showed serum Lp(a) was elevated in chronic consumers of boiled coffee who had a median Lp(a) of 13.0 mg/dL (range 0-130) compared with consumers of filtered coffee who had median Lp(a) 7.9 mg/dL (range 0-144). The effect of coffee on Lp(a) is complex and may follow a biphasic time-course. The type of coffee and the method of preparation appear to be important to determining the effect on Lp(a).

Entities:  

Keywords:  Cafestol; coffee; diterpenes; kahweol; lipoprotein(a)

Mesh:

Substances:

Year:  2017        PMID: 28084806     DOI: 10.1080/10408398.2016.1272045

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  4 in total

Review 1.  The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis.

Authors:  Mohsen Mazidi; Dimitri P Mikhailidis; Abbas Dehghan; Jacek Jóźwiak; Adrian Covic; Naveed Sattar; Maciej Banach
Journal:  Arch Med Sci       Date:  2021-12-14       Impact factor: 3.707

2.  Association of vitamins, minerals, and lead with Lipoprotein(a) in a cross-sectional cohort of US adults.

Authors:  Eric J Brandt; Daniel J Brandt; Nihar R Desai; Erica S Spatz; Khurram Nasir; Arya Mani
Journal:  Int J Vitam Nutr Res       Date:  2021-05-24       Impact factor: 1.784

Review 3.  The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.

Authors:  Peter E Penson; Maciej Banach
Journal:  Curr Atheroscler Rep       Date:  2020-09-18       Impact factor: 5.113

4.  Exposome-wide ranking of modifiable risk factors for cardiometabolic disease traits.

Authors:  Hugo Pomares-Millan; Yan Chen; Alaitz Poveda; Azra Kurbasic; Chirag J Patel; Frida Renström; Göran Hallmans; Ingegerd Johansson; Paul W Franks
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.